It was noteworthy that the PKR inhibitor blocked the growth of HCC1954 breast cancer cells, induced apoptosis, and inhibited DDK-mediated Mcm2 phosphorylation nearly as well as the lead DDK inhibitor PHA-767491. Here, EIF2AK2 is linked to breast cancer.